Laxamind 100 Tablet contains Lacosamide 100 mg as its active ingredient, an antiepileptic agent primarily indicated for the adjunctive treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism contributes to its efficacy in reducing seizure frequency. Laxamind 100 is typically prescribed as part of a comprehensive epilepsy management plan and may be used in both adult and pediatric patients aged 4 years and above. The tablet is administered orally, with dosage individualized based on clinical response and tolerability, often starting at a low dose and gradually titrated to minimize adverse effects. Common side effects include dizziness, headache, nausea, and fatigue, while serious adverse reactions are rare but may include cardiac conduction abnormalities; therefore, caution is advised in patients with pre-existing cardiac conditions. Laxamind 100 should be used under strict medical supervision, with regular monitoring to assess therapeutic efficacy and safety. It is contraindicated in patients with hypersensitivity to Lacosamide or any of its excipients. Concomitant use with other central nervous system depressants requires careful evaluation due to potential additive effects.